Hypoactive Sexual Desire Disorder Support Protocol
Primary Stack
Core supplements with strongest evidenceTraditional adaptogen; may improve sexual desire in both men and women
Supporting Studies (1)
Precursor to sex hormones; may help if levels are low (especially in women)
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsNitric oxide precursor; supports blood flow to genital area
Supporting Studies (1)
Improves circulation; may help with antidepressant-induced sexual dysfunction
Supporting Studies (1)
Traditional use for libido; limited evidence but some positive trials in women
Supporting Studies (1)
Adaptogen; may reduce stress and improve sexual function
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Hypoactive Sexual Desire Disorder (HSDD) is characterized by persistently low sexual desire that causes personal distress. It can affect both men and women, though it's more commonly diagnosed in women.
KEY FEATURES:
CONTRIBUTING FACTORS:
IMPORTANT: HSDD benefits from comprehensive evaluation and often psychological support. This protocol is SUPPORTIVE ONLY.
MEDICAL TREATMENTS:
NON-MEDICATION APPROACHES:
* Maca and DHEA have the most evidence for improving desire.
* Adaptogens may help if stress is a factor.
* Address underlying causes first.
Expected timeline: Supplements may show benefit within 4-8 weeks. Comprehensive treatment including psychological factors often more effective.
Clinical Perspective
HSDD: Deficient or absent sexual fantasies and desire causing distress. DSM-5: Female Sexual Interest/Arousal Disorder (women), Male Hypoactive Sexual Desire Disorder. Prevalence: ~10% women, ~5% men. Workup: hormones (testosterone, thyroid, prolactin), medication review, psychological assessment, relationship factors.
Treatment: Comprehensive approach - address medical, hormonal, psychological, relational factors. Women: flibanserin (daily), bremelanotide (PRN) FDA-approved; testosterone off-label in postmenopausal. Men: testosterone if deficient. All: sex therapy, couples therapy often helpful. Adjust offending medications. Supplements: maca has best evidence; DHEA if levels low; limited evidence for others.
* Maca (B-grade): Adaptogen/libido. Systematic review: (PMID: 20691074). 1.5-3g daily.
* DHEA (B-grade): Hormone precursor. Meta-analysis: (PMID: 25111582). 25-50mg daily supervised.
* L-Arginine (C-grade): Blood flow. Review: (PMID: 23999798). 2.5-5g daily.
* Ginkgo Biloba (C-grade): Circulation. Clinical studies: (PMID: 23888327). 120-240mg daily.
* Tribulus (C-grade): Traditional use. Clinical trial: (PMID: 25131824). 250-750mg daily.
* Ashwagandha (C-grade): Adaptogen. Systematic review: (PMID: 26609282). 300-600mg daily.
Assessment targets: Sexual desire (validated questionnaires like FSDS), relationship satisfaction, quality of life.
Protocol notes: Hormones: check testosterone, SHBG, thyroid, prolactin. Antidepressant-induced: very common (SSRIs especially); consider bupropion add-on or switch. Flibanserin: requires alcohol abstinence; daily dosing; 8-12 weeks to assess. Bremelanotide: self-injected PRN; nausea common side effect. Testosterone in women: off-label; patches/gels; monitor for virilization. DHEA: consider if levels low; women often respond better than men. Couples therapy: often more effective than medication alone. Stress/relationship: address these - supplements won't overcome major relationship problems. Menopause: very common time for HSDD; consider local estrogen for arousal issues alongside HSDD treatment.